Management and outcomes of type 2 diabetes in global Asian populations
Please join us …
When: Tuesday, February 7, 2017, 12–1 p.m.
Where: ICES, G-Wing, Conference Centre (Sunnybrook Health Sciences Centre)
Who: Dr. Calvin Ke, MD, FRCPC; PGY-5, Endocrinology and Metabolism, University of Toronto; MSc to PhD Transfer Candidate, Clinical Epidemiology & Health Care Research, Institute of Health Policy, Management and Evaluation, University of Toronto.
Topic: Management and outcomes of type 2 diabetes in global Asian populations (MSc to PhD transfer defence)
Determining whether diabetes increases the risk of cardiovascular mortality in India
Investigating whether DM2 diagnosis within the young-onset period (age 20 to 40 years) predicts increased cardiovascular complications compared to those diagnosed ≥40 years of age among South Asian, Chinese, and other patients with DM2
Evaluating real-world effectiveness of SGLT2 inhibitors in Chinese patients.